A combination of a relatively low-risk approval process, growing sales, and a very attractive valuation based on management's ...

The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...

Biotech investors hunting for explosive growth may want to look closely at two emerging innovators making significant ...

BioAge Labs ( BIOA +1.02%) is a small drugmaker whose shares have caught fire this year. The company has made clinical ...

Nanobiotix (NASDAQ: NBTX) is a French biotechnology stock, and one that has soared 660% in 2025 as of Nov. 18. That's enough to draw investor attention, and to have many wondering if such torrid ...

But sometimes, this top investor who focuses on innovation does see eye-to-eye with analysts, and the perfect example of this involves a beaten-down biotech stock that Wood has been buying regularly ...

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the best biotech stocks to buy according to Wall Street analysts.

Management has positioned bezuclastinib as a potential alternative to Blueprint Medicines' (BPMT) Ayvakit. This PDGFRα/c-KIT ...

Investor Martin Shkreli's big biotech short position is blowing up after the stock's monumental rally over the past week.